Accès ouvert
2026
article
OpenAlex
Nada Mosallam, Paul M. O’Neill, Monika Lisauskaitė, Christopher M. Woodley et autres
High Resolution Image Download MS PowerPoint Slide Squaramides (SQA) were reported as potent antituberculosis drugs through inhibition of the mycobacterial enzyme adenosine triphosphate (ATP) synthase, which is critical for ATP synthesis. However, squaramide compounds showed high metabolic clearance (CL) despite their promising …
gb, us, in, nl
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Laura N. Jeffreys, Alison Ardrey, Taghreed A. Hafiz, Lauri-Anne Dyer et autres
as a combination strategy to improve therapeutic and pharmacokinetic/pharmacodynamic (PK/PD) indices related to efficacy.
gb, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Laura N. Jeffreys, Shaun H. Pennington, Jack Duggan, Claire H Caygill et autres
A key element for the prevention and management of coronavirus disease 2019 is the development of effective therapeutics. Drug combination strategies offer several advantages over monotherapies. They have the potential to achieve greater efficacy, to increase the therapeutic index of drugs and …
gb
(code pays fourni par la source)
Accès ouvert
2020
preprint
OpenAlex
Laura N. Jeffreys, Shaun H. Pennington, Jack Duggan, Claire H Caygill et autres
ABSTRACT A key element for the prevention and management of COVID-19 is the development of effective therapeutics. Drug combination strategies of repurposed drugs offer several advantages over monotherapies, including the potential to achieve greater efficacy, the potential to increase the therapeutic index …
gb
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Celina Jin, Malick M. Gibani, Shaun H. Pennington, Xinxue Liu et autres
BACKGROUND: The treatment of enteric fever is complicated by the emergence of antimicrobial resistant Salmonella Typhi. Azithromycin is commonly used for first-line treatment of uncomplicated enteric fever, but the response to treatment may be sub-optimal in some patient groups when compared with …
gb, jp, Malawi
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Samantha Donnellan, Ghaith Aljayyoussi, Emmanuel Moyo, Alison Ardrey et autres
Clinical studies of new antitubercular drugs are costly and time-consuming. Owing to the extensive tuberculosis (TB) treatment periods, the ability to identify drug candidates based on their predicted clinical efficacy is vital to accelerate the pipeline of new therapies. Recent failures of …
gb
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Ana Requena‐Méndez, Geraint Davies, David Michael Waterhouse, Alison Ardrey et autres
Background: Poor response to TB therapy might be attributable to subtherapeutic levels in drug-compliant patients. Pharmacokinetic parameters can be affected by comorbidities or the interaction of drugs with food. Objectives: This study aimed to determine the effect of food intake upon pharmacokinetics …
es, gb, pe
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Ghaith Aljayyoussi, Victoria A. Jenkins, Raman Sharma, Alison Ardrey et autres
Tuberculosis (TB) treatment is long and complex, typically involving a combination of drugs taken for 6 months. Improved drug regimens to shorten and simplify treatment are urgently required, however a major challenge to TB drug development is the lack of predictive pre-clinical …
gb
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Weiqian David Hong, Peter D. Gibbons, Suet C. Leung, Richard Kwamla Amewu et autres
Abstract A high-throughput screen (HTS) was undertaken against the respiratory chain dehydrogenase component, NADH:menaquinone oxidoreductase (Ndh) of Mycobacterium tuberculosis (Mtb). The 11000 compounds were selected for the HTS based on the known phenothiazine Ndh inhibitors, trifluoperazine and thioridazine. Combined HTS (11000 compounds) …
gb, Ghana, pt
(code pays fourni par la source)
2017
article
OpenAlex
Diego Vicente da Costa, Julia D.L. Dias, Rita Colen, Priscila Vieira Rosa et autres
Accès ouvert
2015
article
OpenAlex
R. Mlotha, David Michael Waterhouse, Fraction K. Dzinjalamala, Alison Ardrey et autres
BACKGROUND: Current guidelines for dosing of anti-TB drugs in children advocate higher doses for rifampicin and isoniazid despite limited availability of paediatric data on the pharmacokinetics of these drugs, especially from Africa, where the burden of childhood disease remains high. METHODS: Thirty …
Malawi, gb
(code pays fourni par la source)
Accès ouvert
2014
article
OpenAlex
Ana Requena‐Méndez, Geraint Davies, David Michael Waterhouse, Alison Ardrey et autres
Poor response to tuberculosis (TB) therapy might be attributable to subtherapeutic levels in drug-compliant patients. Pharmacokinetic (PK) parameters can be affected by several factors, such as comorbidities or the interaction of TB drugs with food. This study aimed to determine the PK …
pe, es, gb
(code pays fourni par la source)